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Abstract
Background: Current guidelines for the prevention of cardiovascular disease (CVD) recommend diabetes as a CVD risk
equivalent. However, reports that have examined the risk of diabetes in comparison to pre-existing CVD are lacking among
older women. We aimed to assess whether diabetes was associated with a similar risk of total and cause-specific mortality as
a history of CVD in older women.
Methodology/Principal Findings: We studied 9218 women aged 68 years or older enrolled in a prospective cohort study
(Study of Osteoporotic Fracture) during a mean follow-up period of 11.7 years and compared all-cause, cardiovascular and
coronary heart disease mortality among 4 groups: non-diabetic women with and without existing CVD, diabetic women
with and without existing CVD. Mean (SD) age of the participants was 75.2 (5.3) years, 3.5% reported diabetes and 6.8%
reported existing CVD. During follow-up, 5117 women died with 36% from CVD. The multivariate adjusted risk of
cardiovascular mortality was increased among both non-diabetic women with CVD (hazard ratio (HR) 2.32, 95% CI: 1.97–
2.74, P,0.001) and diabetic women without CVD (HR 2.06, CI: 1.62–2.64, P,0.001) compared to non-diabetic women
without existing CVD. All-cause, cardiovascular and coronary mortality of non-diabetic women with CVD were not
significantly different from diabetic women without CVD.
Conclusions/Significance: Older diabetic women without CVD have a similar risk of cardiovascular mortality compared to
non-diabetic women with pre-existing CVD. The equivalence of diabetes and CVD seems to extend to older women,
supporting current guidelines for cardiovascular prevention.
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Introduction
Cardiovascular disease (CVD) is the leading cause of death
among older people [1]. Mortality rates of adults with diabetes
have been shown to be similar to those with preexisting CVD [2]
due to an increased risk of CVD among adults with diabetes [3].
Recent reviews reported a two-fold increased risk for CVD in
adults with diabetes [4,5]. Consequently, current international
guidelines for the prevention of CVD define diabetes as a ‘‘CVD
risk equivalent’’ and suggest similar management of cardiovascular
risk factors in adults with diabetes and those with a history of CVD
[6,7]. However, several cohort studies have found conflicting
results for CVD mortality comparing adults with diabetes and
those with existing CVD [8,9]. Differences in age, gender or the
presence of other cardiovascular risk factors among populations
studied might have accounted for these conflicting data [10,11].
Few data exist comparing mortality risk in older diabetic
women with those with CVD [12,13]. Moreover, there might be
large variations in CVD risk among older adults with diabetes,
related to age at onset or shorter duration of diabetes [14].
Therefore, it remains unclear whether older diabetic women had a
similar risk of mortality as compared to those with a history of
CVD, as suggested by current guidelines for cardiovascular
prevention.
The aim of this study was to determine whether older women
with preexisting diabetes had the same risk of total and
cardiovascular mortality as those with a history of CVD in the
Study of Osteoporotic Fracture (SOF), a large cohort of older
Caucasian women.








































Written informed consent was obtained from all women, and
ethical approval was obtained by each center’s institutional review
board: Kaiser-Permanente Center for Health Research in Port-
land, Ore; University of Minnesota, Minneapolis; University of
Maryland, Baltimore; and University of Pittsburgh, Pittsburgh, Pa.
Study population
Between 1986 and 1988, 9704 Caucasian women (.99% Non-
Hispanic White) aged 65 or older were enrolled in the SOF
cohort, a multi-centre prospective observational study in four
metropolitan areas in the United States (US): Baltimore,
Monongahela Valley near Pittsburgh, Minneapolis and Portland
[15,16]. For this analysis, information was obtained at the third
visit in 1991–1992 in 9218 participants aged 68 years or older who
were alive or not lost to follow-up, because of missing information
for history of CVD at the baseline visit in 1986–1988. Between the
baseline and third visit (mean follow-up 3.5 years), the percentage
of participant lost to follow-up was slightly lower for women with
diabetes (0.44%) as compared to those without diabetes (0.67%).
The primary purpose of SOF was to assess the risk factors for
osteoporotic fractures. Participants were primarily recruited from
population based mailings to community-based residents identified
from voter-registration lists or memberships of large health
maintenance organizations [15]. Women able to walk indepen-
dently were included; those with bilateral hip replacement were
excluded. African American women were also excluded because of
their low incidence of osteoporotic fractures.
Determinants and covariates
Diabetes status was based on self-report of physician diagnosis
or use of anti-diabetic drugs, similar to previous reports from this
cohort [17]. We further categorize diabetic women according to
the duration of diabetes and defined late onset diabetes as having
diabetes since 10 years or less, and long-term diabetes defined as
having diabetes since more than 10 years, based on the self-
reported date of diabetes onset. History of CVD was defined as
coronary heart disease or stroke based on self-report of physician
diagnoses. This self-reported information has been found to be
effective for identifying cardiovascular disease in women [18].
Smoking status and years of education were assessed by interview.
Smoking was classified as never, former and current. Physical
activity was assessed by a modified version of the Harvard Alumni
Questionnaire with information collected on exercise performed
per week over the past year (kcal/wk) and by frequency of walking
[19], as previously done in this cohort [20]. This questionnaire has
been shown to be valid in women [21,22]. Physical examination
was performed with measurement of height, weight, waist girth
and blood pressure according to standard protocols [23].
Hypertension was defined as a blood pressure $140/90 mmHg
[24]. Daily current aspirin use was assessed by self-report. Body
mass index (BMI) (kg/m2) was calculated from measured height
and weight. Fasting total cholesterol, triglyceride and high-density
lipoprotein (HDL) cholesterol levels were measured at the first visit
on a random subsample at one SOF center (n = 958, 10.4%) [17],
and were used in a sensitivity analysis.
Outcomes
Follow up-contacts with ascertainment of vital status were
carried out every 4 months and was 98% complete [16]. The
coordinating center obtained copies of the original death
certificates of all subjects who died. Cause of death was
physician-adjudicated and based upon death certificates and
discharge summaries (if available), with more than 95% of the
underlying cause of death confirmed by the adjudicating physician
[16]. According to ICD-9, cardiovascular mortality (402,404,410–
414,426–445) was defined as mortality from atherosclerosis, stroke
or coronary heart disease [24]. Coronary mortality (410–414) was
defined as myocardial infarction or sudden death.
Statistical analysis
Study participants were classified into 4 groups based on the
presence or absence of diabetes or history of CVD: 1) no diabetes
and no CVD (= reference group), 2) no diabetes and history of
CVD, 3) diabetes and no CVD, and 4) diabetes and history of
CVD. Pairwise comparisons with the no diabetes and no CVD
group were done with t-tests, chi-square or Mann-Whitney rank
sum tests as appropriate. Kaplan-Meier curves and Cox propor-
tional hazards models were used to assess the association between
the 4 groups and mortality. We further examined the equivalence
between late onset and long-term diabetes in comparison to the no
diabetes and no CVD group (reference group), using Wald test
from the Cox model. All models were adjusted for age and for
potential confounders based on biological plausibility: smoking,
physical activity, systolic blood pressure, body mass index and
education. Further adjustment for lipid measurements was
performed in a subsample of 952 participants with complete data
available for cholesterol, HDL, triglycerides and low density
lipoprotein (LDL) cholesterol [17]. We found similar estimates
when using exercise performed per week instead of frequency of
walking; therefore, we retained exercise performed per week in the
final model. Results were reported as hazard ratios (HR) with 95%
confidence intervals (CI).
Results
The mean (SD) age of the 9218 women was 75.2 (5.3) years
(Table 1). Six hundred twenty-four women (6.8%) reported a
history of CVD without diabetes and 318 (3.5%) had diabetes
without CVD. Women with diabetes were more likely to have
hypertension, a larger body mass index, and did less physical
activity than those without diabetes or CVD. Women with history
of CVD only were older, more likely to be former smoker or
aspirin user, to have hypertension, less years of school, and did less
physical activity than those without diabetes or CVD.
Mean study follow-up was 11.7 years to last visit or death.
During follow-up, 5117 (55.5%) women died. Of these deaths,
1823 (35.6%) were attributed to CVD and 717 (14.0%) to
coronary heart disease. Among the 8181 women without diabetes
or CVD, 53% died and a third of these deaths were attributed to
CVD. Among the 95 women with both diabetes and history of
CVD, nearly 80% died and half of these deaths were attributed to
CVD. During follow-up, unadjusted total, cardiovascular and
coronary mortality was similar among women with diabetes and
those with history of CVD (Figure 1).
Women with either diabetes or history of CVD or both
conditions had a significantly higher total, cardiovascular and
coronary mortality than women without diabetes nor CVD
(Table 2). The association between diabetes or history of CVD
with total and cardiovascular mortality remained in the multivar-
iate adjusted models, as well as with further adjustment for aspirin
use. Compared to non-diabetic women without history of CVD,
cardiovascular mortality was elevated in both non-diabetic women
with history of CVD with a multivariate adjusted HR of 2.32 (95%
CI: 1.97–2.74, p,0.001), and in diabetic women without history
of CVD with a multivariate adjusted HR of 2.06 (95% CI: 1.62–
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Table 1. Characteristics of older women by presence or absence of diabetes and cardiovascular disease (CVDa) (N = 9218).
No Diabetes Diabetes
No CVD (n=8181) History of CVD (n=624) No CVD (n=318) History of CVD (n=95)
Age, years 75.065.2 77.066.1** 74.664.8 76.965.8**
Smoking statusb
Never 60.8 56.9 65.9 61.0
Former 29.3 33.9 27.1 24.2
Current 9.9 9.2 6.9 14.7
Smoking, lifetime pack-years 10.3619.5 13.0622.6** 9.2621.5 12.8621.7
Systolic blood pressure, mmHg 141619 144620** 145619** 148620**
Diastolic blood pressure, mmHg 7769 76610 78610 76611
Hypertension 51.0 55.1* 59.8** 63.2*
Physical activity, total kcal/weekc 1169 [504–2241] 880 [336–1866]** 837 [336–1774]** 605 [196–1374]**
Waist girth, cm 83.0611.2 84.0611.0* 91.3612.8** 92.2613.7**
Body mass index, kg/m2 26.364.6 26.164.7 28.665.3** 28.065.4**
Education, years 12.662.8 12.362.9** 12.362.6 12.262.9
Aspirin use 20.0 36.4** 16.3 31.6**
Values are mean 6 standard deviation (SD) or percentages.
*p,0.05,
**p,0.005 for pairwise comparison with no diabetes and no CVD category.
p values were based on t-tests and chi-square tests for trend for multilevel categorical variables.
aCVD was defined as myocardial infarction or stroke.
bFormer smoking was defined as at least 100 cigarettes for the all life. Chi-square tests for trend.
cPhysical activity expressed as median [25%–75%] and Mann-Whitney rank sum test performed.
doi:10.1371/journal.pone.0048818.t001
Figure 1. Survival curves according to the presence of diabetes or history of cardiovascular disease (CVD). a: Total mortality. b:
Cardiovascular disease mortality. c: Coronary heart disease (CHD) mortality.
doi:10.1371/journal.pone.0048818.g001
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2.64, p,0.001). Cardiovascular mortality was highest among
diabetic women with CVD (multivariate adjusted HR 3.93, 95%
CI: 2.71–5.70, p,0.001). In the subsample of 958 (10.4%) older
women with available lipid measurement, the association with
total mortality persisted after further adjustment for LDL-
cholesterol in women with diabetes (multivariate adjusted HR
1.50 (95% CI: 1.11–2.04, p = 0.009) or those with history of CVD
(multivariate adjusted HR 1.78 (95% CI: 1.27–2.51, p= 0.001)
compared to non-diabetic women without CVD.
We further examined the duration of diabetes and compared
total and cause-specific mortality between 624 women without
diabetes but history of CVD (reference group) and 191 women
with late onset diabetes, as well as 126 women with long-term
diabetes, both without history of CVD. Women with late onset
diabetes and no history of CVD reported a first diagnosis of
diabetes at age 60 years or later. The mean duration of diabetes
was 5.8 years in the late onset diabetes group and 19.1 years in the
long-term diabetes group. In age- and multivariate-adjusted
models, diabetic women without CVD had similar cardiovascular
and coronary mortality than non-diabetic women with history of
CVD. Women with long-term diabetes seemed to have a higher
mortality risk than women with late onset diabetes, but with large
confidence intervals (Table 3).
Discussion
In this large population-based study, the risk of cardiovascular
and coronary mortality among older women with diabetes was
similar to those with preexisting CVD. This increased mortality
risk associated with diabetes was particularly apparent for longer
duration of diabetes, and was independent of the presence of other
cardiovascular risk factors.
Previous reviews of observational studies have summarized the
cardiovascular risk associated with diabetes in comparison to those
of adult with a history of CVD [25,26]. However, most of the
individual studies included in these meta-analyses have included
middle-aged adults [8,27,28]. The heterogeneity of the popula-
tions studied in meta-analyses is also an issue, as a recent report
has established epidemiological differences in the cardiovascular
risk among men and women with diabetes [5]. For example,
diabetes might confer a lower risk of coronary heart disease than
previous myocardial infarction in middle-aged men [8], but a
similar or higher risk in middle-aged women [27] and only few
data exist for older women [13]. Therefore, our study provides
important information to better assess the cardiovascular and
coronary risk associated with diabetes in the population-based
group of older women. In contrast to the limited power of
traditional cardiovascular risk factors to predict CVD in older
people [29], our results show that the presence of diabetes in older
women - mean age of 75 years - was associated with total and
cardiovascular mortality beyond demographics and other cardio-
vascular risk factors, and this association was as strong as the
presence of pre-existing CVD.
In our study, the strong association of diabetes with total and
cause-specific mortality might be explained by the long duration of
exposure to diabetes. In middle-aged adults, the duration of





(n=624) No CVD (n=318) History of CVD (n=95)
All-cause mortality
Deaths, N (%) 4371 (53.4) 451 (72.3) 220 (69.2) 75 (79.0)
Incidence, per 1000 person-years (95%CI) 44.5 (43.2–45.8) 78.0 (71.1–85.5)* 69.4 (60.8–79.2)* 113.9 (90.8–142.8)*
Age-adjusted HR (95%CI) 1.00 1.71 (1.55–1.89)* 1.86 (1.62–2.13)* 2.88 (2.29–3.62)*
Multivariate adjusted HR (95%CI)a 1.00 1.63 (1.45–1.83)* 1.96 (1.68–2.28)* 2.69 (2.06–3.51)*
Additionally adjusted for aspirin use (95% CI) 1.00 1.59 (1.41–1.78)* 2.00 (1.72–2.32)* 2.65 (2.02–3.46)*
Cardiovascular mortality
Deaths, N (%) 1479 (18.1) 220 (35.3) 86 (27.0) 38 (40.0)
Incidence, per 1000 person-years (95%CI) 15.0 (14.3–15.8) 38.0 (33.3–43.4)* 27.1 (22.0–33.5)* 57.7 (42.0–79.3)*
Age-adjusted HR (95%CI) 1.00 2.40 (2.08–2.77)* 2.16 (1.74–2.68)* 4.18 (3.03–5.78)*
Multivariate adjusted HR (95%CI)a 1.00 2.32 (1.97–2.74)* 2.06 (1.62–2.64)* 3.93 (2.71–5.70)*
Additionally adjusted for aspirin use (95%CI) 1.00 2.24 (1.89–2.65)* 2.13 (1.66–2.72)* 3.86 (2.67–5.60)*
Coronary mortality
Deaths, N (%) 547 (6.7) 105 (16.8) 45 (14.2) 20 (21.1)
Incidence, per 1000 person-years (95%CI) 5.6 (5.1–6.1) 18.1 (15.0–22.0)* 14.2 (10.6–19.0)* 30.4 (19.6–47.1)*
Age-adjusted HR (95%CI) 1.00 3.12 (2.52–3.86)* 2.97 (2.19–4.04)* 5.79 (3.70–9.08)*
Multivariate adjusted HR (95%CI)a 1.00 2.92 (2.28–3.73)* 2.76 (1.96–3.90)* 5.59 (3.38–9.25)*
Additionally adjusted for aspirin use (95%CI) 1.00 2.80 (2.19–3.59)* 2.84 (2.01–4.01)* 5.49 (3.32–9.08)*
Women with no diabetes and no history of CVD were used as the reference group.
*p,0.001 for comparison with the no diabetes and no CVD group. p values were based on log-rank tests for the rates of death and Wald test from the Cox model for
other variables.
aAdjusted for age, smoking status, physical activity, systolic blood pressure, body mass index and education.
Abbreviations: CVD, cardiovascular disease.
doi:10.1371/journal.pone.0048818.t002
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diabetes plays a major role in the vascular risk [30]. In an
observational study including women with a long duration of
diabetes, diabetes was associated with a greater risk of coronary
mortality than a history of coronary heart disease [12]. In older
men, early-onset diabetes was associated with a higher risk of
coronary heart disease than late onset diabetes [14]. When
stratifying our results between older women with a shorter
duration of diabetes (late onset defined as duration of less than
10 years) and those with long-term diabetes, the latter seemed to
be associated with a worse prognosis. In addition, the nearly 12-
year mean follow-up period of our study implies an exposure to
many years of diabetes in both groups. Thus, in older diabetic
women the duration of diabetes appears to be a key risk factor and
further studies should evaluate its importance for better tailoring
preventive intervention.
Our study has several limitations. We were not able to use the
complete follow-up period of the SOF cohort which started in
1986–1988, because information on history of CVD was only
available at the third visit in 1991–1992. However, there was no
evidence for a selective loss of follow-up for women with diabetes
as compared to the rest of the study population between the first
and the third visit. Moreover, because of the long remaining 12-
year follow-up period of this analysis and the very large number of
deaths, we believe that our estimates are reliable. We may have
also underestimated the number of women with diabetes and those
with known CVD, because information was obtained by self-
report of physician diagnosis or use of anti-diabetic drugs for
women with diabetes. Many women could have had a subclinical
diabetes or CVD. However, these underestimations would have
likely decreased associations with mortality, which we still found to
be statistically significant. Because cholesterol measurements were
available for 10% of the whole population, models including
adjustment with LDL-cholesterol were less precise, although
estimates remained significant. Residual confounding was possible
due to unrecorded diabetes therapy, such as rosiglitazone, a
diabetes medication first approved in 2000 and associated with an
increased incidence of CHD among women with diabetes [31].
However, over the bulk of follow-up time, this drug was not
available. Baseline assessment of predictors was done in 1991–
1992 and change in health behavior across recent decades might
have influenced our results. However, diabetes has been shown to
be associated with the same risk of cardiovascular mortality
independently of the time-period [32]. Causes of deaths were
based upon death certificates, but causes of death were confirmed
by hospital discharge summaries and were adjudicated. These data
have also a number of strengths: the large population of older
women, the long follow-up period with a minimal loss to follow-
up, and the very high number of events.
Conclusions
In this large population-based study of older women, diabetes
and CVD seem to have a similar impact on cardiovascular
mortality and might need similar management as currently
proposed by guidelines for cardiovascular prevention [6,7].
Randomized controlled trials are needed to determine the
Table 3. Comparison of hazard ratios (HR) with 95% confidence intervals (CI) for all-cause, cardiovascular and coronary mortality





No history of CVD
(n=318)
Late onset Diabetesa,
No history of CVD
(n=191)
Long-term Diabetesb,
No history of CVD
(n=126)
All-cause mortality
Deaths, N (%) 451 (72.3) 220 (69.2) 128 (67.0) 92 (73.0)
Incidence, per 1000 person-years (95%CI) 78.0 (71.1–85.5) 69.4 (60.8–79.2) 65.6 (55.1–78.0) 76.4 (62.3–93.7)
Age-adjusted HR (95%CI) 1.00 1.03 (0.87–1.21) 0.98 (0.80–1.20) 1.10 (0.88–1.38)
Multivariate adjusted HR (95%CI)c 1.00 1.14 (0.94–1.38) 1.07 (0.85–1.36) 1.24 (0.96–1.60)
Additionally adjusted for aspirin use (95%CI) 1.00 1.24 (1.01–1.51)* 1.17 (0.92–1.50) 1.35 (1.04–1.76)*
Cardiovascular mortality
Deaths, N (%) 220 (35.3) 86 (27.0) 47 (24.6) 39 (30.9)
Incidence, per 1000 person-years (95% CI) 38.0 (33.3–43.4) 27.1 (22.0–33.5)* 24.0 (18.1–32.0)* 32.4 (23.7–44.3)
Age-adjusted HR (95%CI) 1.00 0.83 (0.64–1.07) 0.75 (0.54–1.03) 0.96 (0.68–1.36)
Multivariate adjusted HR (95%CI)c 1.00 0.87 (0.65–1.16) 0.80 (0.56–1.16) 0.96 (0.65–1.43)
Additionally adjusted for aspirin use (95%CI) 1.00 0.91 (0.67–1.24) 0.85 (0.58–1.24) 1.02 (0.68–1.52)
Coronary mortality
Deaths, N (%) 105 (16.8) 45 (14.1) 23 (12.4) 22 (17.5)
Incidence, per 1000 person-years (95%CI) 18.1 (15.0–22.0) 14.2 (10.6–19.0) 11.8 (7.8–17.7) 18.3 (12.0–27.7)
Age-adjusted HR (95%CI) 1.00 0.89 (0.62–1.27) 0.75 (0.47–1.18) 1.12 (0.70–1.77)
Multivariate adjusted HR (95%CI)c 1.00 0.92 (0.61–1.39) 0.76 (0.44–1.30) 1.14 (0.68–1.93)
Additionally adjusted for aspirin use (95%CI) 1.00 0.99 (0.64–1.53) 0.83 (0.48–1.43) 1.23 (0.72–2.11)
*p,0.05 for comparison with the no diabetes with CVD group.
Women with no diabetes and history of CVD were used as the reference group.
aLate onset diabetes defined as having diabetes since 10 years or less.
bLong-term diabetes defined as having diabetes since more than 10 years.
cAdjusted for age, smoking status, physical activity, systolic blood pressure, body mass index and education.
Abbreviations: CVD, cardiovascular disease.
doi:10.1371/journal.pone.0048818.t003
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intensity, the components and the safety of preventive measures
that should be provided to older diabetic women, particularly if a
history of CVD is additionally reported.
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